Y Intercept (Hong Kong) LTD Harmony Biosciences Holdings, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $3.83 Billion
- Q3 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 58,490 shares of HRMY stock, worth $1.69 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
58,490
Previous 49,454
18.27%
Holding current value
$1.69 Million
Previous $1.56 Million
3.14%
% of portfolio
0.04%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
291Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$191 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$169 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$148 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$47.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$45.7 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.71B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...